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Autophagy is a complex cellular process that involves
dynamic membrane rearrangements under a range of
physiological conditions. It is a highly regulated pro-
cess that plays a role in cellular maintenance and de-
velopment, and has been implicated in a number of
genetic diseases. Upon induction of autophagy, cyto-
plasm is sequestered into vesicles and delivered to a
degradative organelle, the vacuole in yeast or the lyso-
some in mammalian cells. The process is unique in that
it converts material that is topologically intracellular
into topologically extracellular. Autophagy was first
described more than 50 years ago, but it is since the
discovery of the pathway in yeast cells that our knowl-
edge about the molecular events taking place during
the process has expanded. The generation of auto-
phagy-specific mutants in a variety of yeast cell lines
has provided insight into functional roles of more than
15 novel genes, double that number if we include
genes whose products function also in other pro-
cesses. Although we have learned much about auto-
phagy, many questions remain to be answered. This
review highlights the most recent advances in the au-
tophagy field in both yeast and mammalian cells.
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Cell growth and homeostasis is governed by tightly regulated
biosynthetic and catabolic processes. In addition, cells need
a certain degree of flexibility to adapt to changing environ-
mental and/or developmental conditions. This adaptability
may necessitate extensive turnover of cellular components
including organelles, and eukaryotic cells harbor two power-
ful hydrolytic machineries for such purposes: the proteasome
and the lysosome/vacuole. In both degradative systems, the
hydrolytic arsenal is compartmentalized to avoid unregulated
breakdown. In the case of the proteasome, only ubiquitin-
tagged proteins are transported into the particle core where
the proteolytic activity is hidden. The lysosome/vacuole, how-
ever, constitutes a hydrolase-packed organelle and imposes
the need for mechanisms for delivering substrates destined
524
for degradation across a delimiting membrane. Accordingly,
eukaryotic cells have evolved a range of complex processes




Autophagy was originally described as a cellular response
to starvation. In mammalian cells deprived of serum and
amino acids, vesicles containing bulk proteins and organ-
elles rapidly appear within the cytosol and lysosome. These
autophagosomes have a half-life in the range of minutes
before lysosomal hydrolases start to degrade the macro-
molecular cargo, allowing the release of the monomeric
units back into the cytosol. This form of autophagy is
sometimes referred to as macroautophagy (Figure 1) and
seems to take place in all eukaryotic cells, although the
morphology may appear different from cell to cell. Yeast
cells form double-membrane-bound autophagosomes with
a diameter of 300–900nm, while some mammalian cells
form multilamellar autophagosomes. Freeze-fracture studies
of autophagosomes from rat hepatocytes and of yeast cells
show that these vesicles are almost completely lacking
transmembrane proteins (1,2). The relative absence of
membrane proteins fits with a role for the autophagosome
as a carrier vesicle that is destined to be degraded by the
hydrolytic arsenal of the lysosome/vacuole.
Starvation-induced autophagy is generally assumed to be
nonselective with the purpose of generating building blocks
needed by the cells to survive starvation. Autophagy allows
haploid yeast cells to survive severe starvation for weeks;
without autophagy, yeast cells start to die within 2 days
under conditions of nutrient deprivation. Diploid yeast cells
will not sporulate upon starvation if autophagy is inhibited.
In mammalian organisms, organs with a high capacity for
autophagy, such as the liver, may support the rest of the
organism with macromolecular building blocks during star-
vation. Autophagy is probably the main mechanism for
degradation of long-lived proteins and the only mechanism
for turnover of organelles including mitochondria and peroxi-
somes. Although this turnover generally may occur randomly,
degradation of peroxisomes by the related process of pex-
ophagy may be highly selective. This sometimes selective
property of autophagy has led to suggestions that autophagy
may be an essential process during embryogenesis and cell
differentiation.
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Figure1: Morphology of autophagy, pexophagy and the Cvt pathway in yeast. Macroautophagy, macropexophagy and the Cvt
pathway involve the formation of sequestering vesicles in the cytosol that engulf bulk cytoplasm, peroxisomes or prApe1 and Ams1, respec-
tively. Following completion, these vesicles target to and fuse with the vacuole, releasing single-membrane vesicles within the lumen where
they are degraded, allowing maturation of prApe1 and recycling of cytoplasm. In microautophagy and micropexophagy, cytoplasm and
peroxisomes, respectively, are taken up directly at the vacuole surface.
Pexophagy
Selective autophagy of peroxisomes has been shown in both
yeast and mammalian cells. After the cessation of treatment
with peroxisome proliferators, the superfluous peroxisomes
are degraded in a process that is inhibited by 3-methyladen-
ine, a characteristic typical of autophagy. This degradation is
also inhibited by long-chain fatty acids, substrates for peroxi-
somal b-oxidation. Most yeast cells are also capable of selec-
tive autophagy of peroxisomes. Saccharomyces cerevisiae
grown on oleic acid, and Pichia pastoris and Hansenula poly-
morpha grown on methanol, will induce peroxisomal en-
zymes leading to a dramatic expansion of the peroxisomal
compartment and/or the number of peroxisomes. If a differ-
ent carbon source such as glucose is added, these peroxi-
somes are no longer required and are rapidly degraded
within the vacuole. In S. cerevisiae and H. polymorpha the
process used to take up the peroxisomes resembles star-
vation-induced macroautophagy, involving cytosolic seques-
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tration within autophagosome-like vesicles (Figure 1) (3,4).
This process is termed macropexophagy.
P. pastoris utilizes macropexophagy during ethanol adap-
tation and micropexophagy during glucose adaptation.
Micropexophagy resembles a form of autophagy that has
been seen to take place in vivo in mammalian cells as well
as by purified mammalian lysosomes, and involves a small-
scale invagination of the lysosomal membrane (Figure 1).
During micropexophagy in P. pastoris, the whole vacuole en-
gulfs the peroxisomes. This can be followed by electron and
fluorescence microscopy, allowing pexophagy genes to be
functionally classified as to whether they are involved in in-
duction of pexophagy, recognition and sequestration of per-
oxisomes, homotypic fusion completing the uptake, and/or
degradation (5). Although macropexophagy and micropex-
ophagy of peroxisomes are morphologically distinct, they
seem to require the same set of proteins as starvation-in-
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duced macroautophagy (4,6). So far, only one protein has
been described that is required for pexophagy but not for
autophagy in P. pastoris and S. cerevisiae: Gsa9 and Cvt9,
respectively (7). Interestingly, Cvt9 is also required for a
constitutive, selective form of autophagy termed the cyto-
plasm-to-vacuole-targeting (Cvt) pathway in S. cerevisiae.
The Cvt pathway
Although the term autophagy reflects cellular self-cannibal-
ism, this pathway may also serve a biosynthetic purpose in S.
cerevisiae. The vacuole-resident hydrolase aminopeptidase I
(Ape1) is not delivered to the vacuole by the ER and Golgi
route, but instead is synthesized as a precursor (prApe1) in
the cytosol, where it rapidly forms a dodecamer of 732kDa
(Figure 1). This dodecamer forms a higher-order complex,
and the delivery of this large complex to the vacuole requires
the same set of proteins as starvation-induced autophagy
and pexophagy (4,6). The Cvt pathway also utilizes some
proteins that are not required for nonspecific macroauto-
phagy, such as Cvt9 (7). Another component specific to the
Cvt pathway is Cvt19, a peripheral membrane protein shown
in vivo and in vitro to have the characteristics of a prApe1
receptor (8). Cvt19 interacts with the prApe1 propeptide that
is known to contain vacuolar targeting information and is re-
quired for import of prApe1 under both vegetative and star-
vation conditions, but is not needed for nonspecific auto-
phagy. In addition, cvt19D is the only characterized cvt or apg
mutant that is not defective for pexophagy, suggesting that
its role is restricted to biosynthetic import. Cvt19 is also re-
quired for delivery of a second resident hydrolase, a-man-
nosidase (Ams1), to the vacuole (9). Similarly to prApe1,
Ams1 oligomerizes in the cytosol before sequestration, but it
is not yet known whether they travel to the vacuole separately
or in a shared vesicle.
A third protein that is required primarily for the Cvt pathway
is Vac8, which is also involved in early vacuole migration dur-
ing cell division. Vac8 interacts with Apg13 and may be part
of a regulatory complex that controls the conversion between
the Cvt and autophagy pathways (10) (see ‘The Switching
Complex’ below). In addition to these proteins, the formation
of Cvt vesicles also seems to require a different SNARE com-
plex than the formation of autophagosomes (see ‘Fusion and
Degradation’ below).
Autophagy-related degradation pathways
Several vacuolar/lysosomal degradation pathways besides au-
tophagy have been described in mammalian and yeast cells,
but it is not yet clear if they share any components with auto-
phagy, except in the final degradation step. The best-de-
scribed of these is chaperone-mediated autophagy, a process
characterized in mammalian cells that involves the recognition
of a degenerate KFERQ pentapeptide motif in proteins by the
heat-shock cognate protein Hsc73, followed by Lamp2a-de-
pendent translocation across the lysosomal membrane (re-
viewed in 11). A similar mechanism for vacuolar in vitro uptake
of glyceraldehyde-3-phosphate dehydrogenase in S. cerevis-
iae requiring Hsp70s has recently been described (12).
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The activity of Hsp70 protein Ssa2 is also required for vacuo-
lar degradation of fructose 1,6-bisphosphatase (FBPase) by
the Vid pathway. FBPase is a key regulatory enzyme in the
gluconeogenesis pathway, and is degraded upon addition of
glucose. Vacuolar degradation of FBPase involves import of
the enzyme into single membrane-bound Vid vesicles of
30nm that subsequently fuse with the vacuole. The protein
translocation requires Vid24, Ssa2 (13) and multiubiquitin
chain formation by Ubc1 (14). A population of FBPase may
also be degraded through the action of the proteasome.
A microautophagic pathway proposed to play a role in vacuo-
lar membrane breakdown has recently also been described
in S. cerevisiae (Figure 1). However, vacuolar uptake by this
pathway is only partially blocked in autophagy mutants, indi-
cating that this process may not be analogous to micropex-
ophagy in P. pastoris (15,16).
Regulation of Autophagy
The mechanism by which cells sense starvation and initiate
a signal transduction event that induces autophagy is largely
uncharacterized. In mammalian cells, regulatory factors may
include protein kinases (such as Tor, and Erk1/2) and phos-
phatases (such as PP2A), G-proteins, calcium, and lipid ki-
nases (reviewed in 17). In S. cerevisiae, the regulation in-
volves a switch from the Cvt pathway, which operates under
vegetative conditions, to autophagy. In P. pastoris, the onset
of microautophagy of peroxisomes during glucose adap-
tation has been shown to require phosphofructokinase I
(Pfk1) independent of the enzyme’s glycolytic activity. Control
of ethanol-induced macropexophagy probably occurs
through an alternate mechanism that may involve glyoxylate
(reviewed in 17). In agreement with the separate regulation
of these two modes of pexophagy, pfk1/gsa1 mutants are
not defective for macropexophagy.
Tor2
The immunosuppressive drug rapamycin when complexed
with FKBP inhibits Tor kinases in yeast and mammalian cells.
By inhibiting Tor2, rapamycin mimics the effect of starvation,
leading to a variety of cellular responses associated with G0
arrest (reviewed in 18), including alterations in the phos-
phorylation patterns of autophagy-specific proteins, in-
creased level of the autophagy protein Aut7, and the onset
of nonselective autophagy.
Trimeric G proteins
Overexpressing the alpha-subunit of the heterotrimeric G-
protein Gi3 in HT-29 cells induces autophagy. The GDP-
bound form of the protein promotes autophagic uptake,
while GTP-bound Gai3 reduces autophagy. Hydrolysis of GTP
on Gai3 and stimulation of autophagy is accelerated by Ga-
interacting protein (GAIP). The activity of GAIP is further up-
regulated by phosphorylation by Erk1/2 MAP kinases, which
in turn are phosphorylated in the absence of amino acids
(19). The autophagy deficiency seen with a GTPase-deficient
Molecular Mechanism of Autophagy
mutant of the Gai3 protein may be partly overcome by overex-
pressing the Vps15 homolog p150 or synthetic phosphoinos-
itide 3-phosphate, suggesting that Gai3 acts upstream of the
type III phosphoinositides.
Phosphoinositide 3-kinase
While type I phosphoinositide 3-phosphates are inhibitory for
autophagy, type III are required (20). In mammalian cells, the
PI 3-kinase inhibitor wortmannin is a potent inhibitor of auto-
phagy, and it has also been shown that the selective auto-
phagy inhibitor 3-methyladenine acts by inhibiting PI 3-ki-
nase (21). Reduction of type III PI 3-kinase activity with anti-
sense RNA greatly reduces autophagy in HT-29 cells (20). In
S. cerevisiae, the PI 3-kinase Vps34 is a key enzyme in sev-
eral transport events leading to the vacuole. Vps34, complex-
ed with the protein kinase Vps15 and the accessory proteins
Vps38 and Vps30/Apg6, is essential for sorting of CPY to
the vacuole, while a similar complex in which Vps38 is re-
placed with Apg14 is essential for autophagy (22) (Figure 2).
A putative human homolog of Vps30/Apg6, the Bcl-2-inter-
acting, coiled-coil protein Beclin 1, is able to complement
only the autophagy deficiency in yeast cells lacking Vps30/
Apg6 (23). Beclin 1 is a candidate tumor suppressor, and
reintroduction of Beclin 1 into the breast cancer cell line
MCF7 not only restores autophagy in these cells but also
suppresses the tumorigenicity and other malignant charac-
teristics associated with cancer cells. In HeLa cells, all of Be-
clin 1 is associated with PI 3-kinase activity and most of this
complex is localized to the trans-Golgi network (24). This
localization of Beclin 1 could suggest a role for the phosphati-
dylinositol 3-phosphates in sorting of proteins to the auto-
phagic organelle rather than as a regulatory effector. Morpho-
Figure2: Two different PI 3-kinase complexes are involved in vacuolar protein targeting. Apg14 and Vps38 are specific compo-
nents of a PI 3-kinase complex that is required for the autophagy/Cvt pathway or the Vps pathway, respectively. Vps30/Apg6, the Vps15
protein kinase and the Vps34 PI 3-kinase are common to both pathways. Adapted from Kihara et al., J Cell Biol 2001;152:519–530.
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logical studies in H. polymorpha and P. pastoris suggest that
the activity of Vps34/Pdd1 and Vps15 are required at an early
stage of selective and nonselective autophagy (3,25).
Molecular Events in Autophagosome
Formation
Although we still do not know how autophagosomes form or
all the factors required for this process, characterization of
the known autophagy proteins has provided significant in-
sight into how the proteins interact and function. Almost all of
this knowledge comes from studies in yeast cells, but protein
homologs exist in mammalian cells, and the characterization
of these proteins and their involvement in autophagy has just
begun. Two molecular pathways seem to play an important
role in the initiation and sequestration process.
The switching complex
As discussed above, S. cerevisiae switches between the Cvt
pathway and autophagy depending on nutrient conditions. A
protein complex that may play a role in this regulatory switch
has been identified (7,10,26). A central component in this pro-
tein complex is Apg1, a serine/threonine protein kinase essen-
tial to both starvation-induced and selective autophagy (Figure
3). The substrate for this kinase is unknown, but using a syn-
thetic substrate it has been shown that the kinase activity of
Apg1 is stimulated by starvation and rapamycin (26). Although
the phosphorylation of Apg1 itself is reduced upon starvation,
activation of this protein appears to be controlled in part
through binding to Apg13. Apg13 is hyperphosphorylated
under rich conditions, while starvation induces dephos-
phorylation (10,26). Apg13 also displays a higher affinity for
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Figure3: The Apg1 kinase complex includes components that are specific for the Cvt pathway or macroautophagy. The Apg1
kinase interacts with Cvt9 and Vac8, two components that are specific for the Cvt pathway, and Apg17, a protein that is required only for
autophagy. The interaction with Vac8 appears to be indirect and mediated through Apg13. The phosphorylation of at least Apg1 and Apg13
varies depending on the nutritional state of the cell. In starvation conditions or following treatment with rapamycin, both proteins are partially
dephosphorylated and interact with a higher affinity. The phosphorylation state of Apg17 has not been determined.
Apg1 under starvation conditions. The tighter binding of
Apg13 to Apg1 and subsequent activation of Apg1 occur con-
comitantly with a switch from selective cargo uptake to non-
selective, bulk autophagy. Apg13 is further associated with
Vac8, the vacuolar inheritance protein that also acts in the Cvt
pathway but is not essential for starvation-induced autophagy
(10). Vac8 is also a phosphoprotein and may help to facilitate
phosphorylation of Apg13.
Apg1 also interacts with two other proteins. One of these,
Apg17, is not required for the Cvt pathway but has been pro-
posed to play a function in the Apg1–Apg13 interaction (26).
The other, Cvt9, is not required for non-selective autophagic
import (7). Cvt9 is a large coiled-coil protein that localizes to
a punctate structure close to the vacuole in S. cerevisiae and
plays a role in both the Cvt pathway and pexophagy. In P.
pastoris, the Cvt9 homolog Gsa9 also stains the vacuolar
membrane. During micropexophagy, GFP-tagged Gsa9
seems to mediate tethering of the vacuolar membrane to the
peroxisomes. In S. cerevisiae, Cvt9 stabilizes the binding of
prAPI to the sequestering membrane. Cvt9 interacts with it-
self, possibly through the coiled-coil domain, and this could
potentially crosslink the Apg1 complex into a higher-order
structure required early in the sequestration process.
A putative homolog of Apg1 in C. elegans, Unc-51, is re-
quired for normal neuronal elongation. Ultrastructural analysis
of the unc51 mutant revealed abnormal vesicles and mem-
branous structures within the axons. A defect in axonal
elongation has also been found by overexpressing a domi-
nant negative mouse homolog in cultured cerebellar granule
neurons (27). Two putative human homologs of Apg1 exist:
ULK1 and ULK2. ULK1 has been shown by yeast two-hybrid
screening to interact with GATE-16 and GABARAP, two
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homologs of the yeast autophagy protein Aut7 (see ‘The
Conjugation Cascade’ below) (28).
The conjugation cascade
A hallmark in the autophagy field was the discovery that the
two autophagy proteins Apg5 and Apg12 are physically con-
nected through the action of Apg7 and Apg10 (29) (Figure 4).
Apg7 and the P. pastoris homolog Gsa7 were identified as
homologs of the ubiquitin-activating enzyme E1, with particu-
larly strong homology around the ATP-binding domain
(6,30,31). Upon activation of an essential cysteine in Apg7 with
ATP, the C-terminal glycine in Apg12 is bound to Apg7 through
a thioester linkage. The binding of Apg12 requires the C-ter-
minal 40 amino acids of Apg7 and facilitates dimerization of
Apg7 (32). Apg12 is next transferred to a cysteine in Apg10,
which acts as an E2 enzyme in conjugating Apg12 through an
isopeptide bond to internal lysine 149 in Apg5 (33). The small
coiled-coil protein Apg16 binds preferentially to the conjugate
and may crosslink conjugates through homo-oligomerization
(34). Human homologs of Apg5 and Apg12 are also conju-
gated. In cultured mouse embryonic stem cells, Agp5 is re-
quired for autophagosome formation, and GFP-tagged human
Apg5 can be used to trace the formation of autophagosomes
from crescent-shaped cytoplasmic structures (35). Conju-
gation is not required for targeting of Apg5 to the sequestering
membrane but for elongation of the membrane into cup-
shaped structures. However, upon completion of the seques-
tration process, neither of the conjugation proteins remains as-
sociated with the nascent autophagosome.
A second conjugation event involving the membrane recruit-
ment of Aut7 is also needed for autophagy, pexophagy and the
Cvt pathway (36,37) (Figure 4). Aut7 is a small protein without
sequence similarity to ubiquitin but with a three-dimensional
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Figure4: Membrane recruitment of Aut7 involves two separate conjugation reactions. Apg12 is activated by the E1-like enzyme
Apg7 and conjugated to Apg5 through the action of Apg10. Apg16 dimerizes and links a pair of Apg12–Apg5 conjugates. Aut7 is processed
by the Aut2 cysteine protease, activated by Apg7 and conjugated to phosphatidylethanolamine (PE) by Aut1. Attachment of PE and the
action of the Apg12–Apg5 conjugation complex are required for membrane recruitment of Aut7.
structure predicted to contain an ubiquitin fold (38). Aut7 is
synthesized with a C-terminal arginine that is immediately
clipped off by Aut2, a cysteine protease, exposing a glycine
(39,40). Again, Apg7 is the activating enzyme that forms a
thioester bond with the exposed glycine of Aut7. The Aut1 pro-
tein, acting like an E2 enzyme, then conjugates the protein to
phosphatidylethanolamine (41). Aut7 is the only autophagy
protein upregulated (10–20-fold) by starvation and displays a
strong perivacuolar localization that is dependent on the
Apg12–Apg5 conjugation pathway, as well as lipidation by
Aut1. One of the primary distinguishing features between the
Cvt pathway and autophagy is the size/capacity of the seques-
tering vesicles. If upregulation of Aut7 is inhibited during star-
vation by protein synthesis inhibitors, abnormally small auto-
phagosomes are formed (42). A function for Aut7 in elongation
of the sequestering membrane has therefore been proposed.
Three mammalian homologs, seemingly having very different
functions, exist for Aut7: GABARAP, GATE-16 and MAP-LC3.
GABARAP binds GABAA-receptor and promotes clustering of
the receptor and binding to microtubules (43). GATE-16 was
identified as a protein stimulating intra-Golgi transport in vitro
and has been shown by immunofluorescence to reside in the
Golgi complex (44). GATE-16 interacts with NSF and the
Golgi v-SNARE GOS-28. S. cerevisiae Aut7 may substitute
for GATE-16 in vitro, and interacts physically with the yeast
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v-SNAREs Bet1 (ER to Golgi transport) and Nyv1 (vacuolar
inheritance), and genetically with Sec22 (ER to Golgi), sug-
gesting that Aut7 may exert several functions in yeast (45).
Finally, MAP-LC3, is enriched as a processed form in auto-
phagosomal membranes in HeLa cells (46). Removal of the
last 22 amino acids as well as a second modification is
required for autophagosome association (46) as well as
conjugation of Apg12 to Apg5 (35). Interestingly, all three
Aut7 homologs interact physically with the human homolog
of Apg7 and may therefore be conjugated to proteins or
lipids (47).
Fusion and degradation
The mechanism of formation/completion of the sequestering
vesicle in macroautophagy and the Cvt pathway is far from
understood. However, this process is likely to involve compo-
nents in a SNARE complex, either during the addition of new
membrane for vesicle expansion, or in a final homotypic fusion
event that completes the vesicle. The syntaxin and Sec1
homologs Tlg2 and Vps45, respectively, are required for im-
port of prApe1 but not autophagy (48). This finding suggests
that different SNARE components are required for autophagy
and the Cvt pathway, and possibly that different membranes
are used to form the sequestering vesicles. Following com-
pletion of the double-membrane vesicle in the cytosol, the
outer membrane fuses with the vacuole/lysosome, releasing
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the inner single-membrane vesicle into the lumen. A distinct
docking step has not been shown to occur in autophagic im-
port but is likely to take place, based on the overlap of the fu-
sion machinery with that of other vacuolar import pathways, as
well as homotypic vacuole fusion (reviewed in 17). Ypt7, Vam3,
Vti1 and the components of the class C/HOPS complex are re-
quired for all characterized fusion events involving the vacuole.
After release into the lumen, the subvacuolar vesicle is de-
graded to allow access to the cargo. Degradation must be
regulated to prevent breakdown of the outer vesicle mem-
brane that is now continuous with the vacuole/lysosome
membrane. Degradation requires a low pH, proteinase B
(Prb1) and Cvt17. Prb1 is a hydrolase that is involved in the
activation of many other vacuolar zymogens. Thus, Prb1 may
play an indirect role in vesicle breakdown. At present, Cvt17
is the only putative lipase that has been identified as having
a role in subvacuolar vesicle degradation and has homology
with triacylglycerol lipases (49). The mechanism or site of
action of Cvt17 is unknown, as the protein was not reported
to be present at high levels in the vacuole.
Concluding Remarks
Autophagy is a common cellular process that is involved in a
wide range of physiological events. It is an essential process
in microorganisms under stress conditions such as starvation,
a situation that is frequently encountered in the natural en-
vironment. In multicellular organisms, autophagy is a homeo-
static mechanism that may represent the first stage in a cel-
lular/tissue response that can range from autophagy to
apoptosis and necrosis (50). In this sense, autophagy is a
protective mechanism that can eliminate cells that would
otherwise prove harmful to the organism. In fact, autophagy
has been suggested to play a critical role in type II (nonapop-
totic) programmed cell death (reviewed in 50). Defects in
autophagy have been linked to numerous diseases in mam-
mals, including cancer, cardiomyopathy and neurodegenera-
tive defects. Continued analysis of autophagy and the related
processes of cytoplasm to vacuole targeting and pexophagy
in both yeasts and mammalian cells will provide an exciting
avenue for future work in this important area of cell biology.
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